Abstract
An open, single, crossover, pharmacokinetic study of GML-1 (dose 50 mg/kg) in rabbits after its oral administration in tablets and alone as a substance is carried out. The following pharmacokinetic parameters are calculated: the maximum concentration of GML-1 in blood plasma (Cmax) of rabbits, the time required to reach Cmax, the area under the concentration-time curve, the half-time of GML-1, and the relative bioavailability. The GML-1 concentration is detected with the use of the HPLC-MS (ion trap) by the daughter ions. The relative bioavailability of GML-1 in tablets is 101.72 ± 19.96% in comparison to the substance.
Similar content being viewed by others
REFERENCES
Yarkova, M.A., Mokrov, G.V., Gudasheva, T.A., and Seredenin, S.B., Pharm. Chem. J., 2016, vol. 50, no. 8, p. 501.
Kang, H.Ch., Huh, K.M., and Bae, Y.H., J. Controlled Release, 2012, vol. 164, no. 3, p. 256.
Bardakov, A.I., Litvin, A.A., and Slivkin, A.I., Biofarmatsevticheskie podkhody v razrabotke i otsenke gotovykh lekarstvennykh form (Biopharmaceutical Approaches in the Development and Evaluation of Finished Dosage Forms), Krasnyuk, I.I., Ed., Voronezh: Voronezh. Gos. Univ., 2010.
Firsov, A.A., Zherdev, V.P., Portnoi, Yu.A., et al., Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (Guidelines for Conducting Preclinical Studies of Pharmaceutical Preparations), Mironov, A.N., Ed., Moscow: Grif, 2013, part 1.
Novitskiy, A.A., Bochkov, P.O., Litvin, A.A., Zherdev, V.P., and Blynskaya, E.V., Moscow Univ. Chem. Bull. (Engl. Transl.), 2017, vol. 72, no. 6, p. 322.
Validatsiya analiticheskikh metodik dlya proizvoditelei lekarstv. Tipovoe rukovodstvo predpriyatiya po proizvodstvu lekarstvennykh sredstv (Validation of Analytical Methods for Drug Manufacturers: Model Guide of the Company for the Production of Medicines), Beregovykh, V.V., Ed., Moscow: Littera, 2008.
Sergienko, V.I. and Bondareva, I.B., Matematicheskaya statistika v klinicheskikh issledovaniyakh (Mathematical Statistics in Clinical Studies), Moscow: GEOTAR-Media, 2001.
Funding
This study was supported by the Ministry of Education and Science (state contract no. 14. N08.12.0087).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. All applicable international, national and/or institutional principles for the care and use of animals were followed.
Additional information
Translated by M. Novikova
About this article
Cite this article
Novitskiy, A.A., Litvin, A.A., Shevchenko, R.V. et al. Comparative Pharmacokinetics and Relative Bioavailability of a New Anxiolytic GML-1 in Tablet Form. Moscow Univ. Chem. Bull. 74, 204–207 (2019). https://doi.org/10.3103/S0027131419040060
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0027131419040060